Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7381 p774
24/31 December 2005

This article
Reprint   Photocopy

PDF 40K, Acrobat Reader

Letters

· Medicines use reviews
· COX-2s
· Registration
· Other professions
· Prescription charges
· CPD
· Fitness to practise


Letters to the Editor

Fitness to practise

Lack of communication

From Mr P. B. Lowe, MRPharmS

As community pharmacy development manager for a primary care trust I find it surprising that information relevant to the fitness to practise of pharmacists is not provided to PCTs by the Royal Pharmaceutical Society as soon as it becomes evident.

In the light of the serious implication of inadequate governance of professional practice brought to light by the Shipman Inquiry one would expect the pooling of resources among all bodies with a professional or a contractual responsibility to monitor clinical performance. Yet even when the Statutory Committee strikes off a pharmacist the body responsible for commissioning his services is likely to be informed opportunistically via the pages of The Journal.

Peter Lowe
Newcastle upon Tyne

 

MANDIE LAVIN, director of fitness to practise and legal affairs, Royal Pharmaceutical Society, replies:

Decisions of the Statutory Committee are published both in the pages of The Pharmaceutical Journal and on the Society’s website in the week following the hearing.

In October 2005, the Council set out its policy on disclosure of information abut a member’s fitness-to-practise history. When sent the Notice of Inquiry, members facing an inquiry are now routinely asked to provide information about their employers and primary care organisations. Although the Society does not presently have the powers to compel disclosure of that information, disclosure to the Society is likely to become a legal requirement under new legislation expected next year. At the conclusion of any hearing where an adverse decision has been reached, a copy of the decision is now sent to the member’s employer and the PCO, where details are known.

The Statutory Committee sits for three or four consecutive days, usually in the third week, of each month. It is the responsibility of all employers to check the Society’s website regularly to see if any adverse findings have been made against one of their employees. This is particularly so in the case of those of employing locums.

Send your letter to The Editor

Previous Topic (Continuing professional development)

Back to Top


©The Pharmaceutical Journal